Home > Legal Library > Advanced Search > Search Results

Join Matindale-Hubbell Connected

Search Results (285)

Documents on Products Liability, Pharmaceuticals, Internet & E-Commerce

View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLWebsite Terms of Use Spawn Wave of Lawsuits Against Online Retailers Under New Jersey’s Truth-in-Consumer Contract Warranty and Notice Act
David Jay, Jason Kislin, Paige Nestel; Greenberg Traurig, LLP;
Legal Alert/Article
July 7, 2016, previously published on June 21, 2016
Although New Jersey’s Truth-in-Consumer Contract Warranty and Notice Act (TCCWNA) was enacted over 30 years ago, there has been a dramatic spike in the statute’s popularity amongst plaintiff’s attorneys in recent months - leading to dozens of lawsuits, class actions, and threats...


HTMLFDA Publishes Revised Guidance on Product Tracing Requirements for Dispensers
Carolyn A. Alenci, Rachael G. Pontikes; Duane Morris LLP;
Legal Alert/Article
November 30, 2015, previously published on November 4, 2015
On November 27, 2013, the Drug Supply Chain Security Act (DSCSA) was enacted “to build an electronic, interoperable system by November 27, 2023, which will identify and trace certain prescription drugs as they are distributed in the United States.” This year, trading partners were...


HTML$8.2M Verdict In Texas Benzene Trial Against DuPont
Waters Kraus LLP;
Legal Alert/Article
October 26, 2015, previously published on October 22, 2015
A Dallas, Texas jury has awarded $8.2 million to a 60-year-old Texas man battling MDS/AML, a form of leukemia caused by his exposure to benzene contained in paint and thinners manufactured by E.I. Du Pont De Nemours (DuPont). Virgil Hood handled DuPont’s toxic products on the job daily in...


HTMLPublic Statements Made by Pharmaceutical and Biotech Company Executives May Raise FDA's Hackles if They Do Not Meet Basic Requirements for Promotional Communications
Joanne S. Hawana; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.;
Legal Alert/Article
June 26, 2015, previously published on June 23, 2015
For players in the highly regulated pharmaceutical and health care industries, it is common knowledge that manufacturers and distributors of FDA-regulated products are required to promote their products in compliance with the Federal Food, Drug, and Cosmetic Act (the Act) and FDA’s...


HTMLFederal Judge Makes Important Ruling in Xarelto Lawsuits
Waters Kraus LLP;
Legal Alert/Article
June 17, 2015, previously published on June 1, 2015
As the number of Xarelto lawsuits rises due to the drug’s link to uncontrollable bleeding in patients, cases filed in federal court have been assigned to a single judge in the Eastern District of Louisiana — Judge Eldon Fallon. In May 2015, Judge Fallon ordered lawyers in the Xarelto...


HTMLWhat’s Really in Your Supplements?
Selina A. Billington; Wilson Elser Moskowitz Edelman & Dicker LLP;
Legal Alert/Article
April 15, 2015, previously published on March 16, 2015
New York State Attorney General’s Investigation Has Sparked a Coalition of State Attorneys General Against Herbal Supplement Manufacturers: What does this mean for the industry as a whole in terms of product liability exposure?


HTMLJ&J and Bayer Launch New Xarelto Study
Waters Kraus LLP;
Legal Alert/Article
April 7, 2015, previously published on March 20, 2015
Johnson & Johnson and Bayer are reportedly seeking additional Food and Drug Administration (FDA) approval for Xarelto, the companies’ lucrative blood thinner that many lawsuits claim can cause injuries and death from uncontrollable bleeding.


HTMLStates with Medical Marijuana See Falling Opioid Death Rate
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
Legal Alert/Article
March 25, 2015, previously published on January 23, 2015
Researchers from the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center discovered the number of opioid overdoses decreased overtime in states with legalized marijuana.


HTMLFDA Establishes the Office of Pharmaceutical Quality
Duane Morris LLP;
Legal Alert/Article
March 3, 2015, previously published on February 23, 2015
In a press conference earlier this year, Dr. Janet Woodcock, head of the U.S. Food and Drug Administration's (FDA) pharmaceutical division, stated that the FDA has been working on "establish[ing] consistent quality standards for all drugs, whether brand name or generic" over the past 10...


HTMLFDA Publishes Second Draft Guidance for Further Clarification of Drug Supply Chain Security Act
Carolyn A. Alenci, Frederick R. Ball; Duane Morris LLP;
Legal Alert/Article
December 10, 2014, previously published on November 17, 2014
Earlier this year, the U.S. Food and Drug Administration (FDA) requested information and commentary for the implementation of the Drug Supply Chain Security Act (DSCSA) that in part "establishes a Federal system for tracing prescription drug products through the pharmaceutical distribution...


View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>